Based on TCGA database, high C6orf141 expression was noted to be significantly correlated with poor survival rates in patients with liver cancer, pancreatic cancer, kidney cancer, and gastric cancer. This evidence concerns the gene C6orf141 and familial pancreatic carcinoma.